Chugai Pharmaceutical Co., Ltd.
CHGCF
Get informed when a big investor buys or sells
+ FollowMarket Cap$9.91T
Close$
Share Statistics
| Market cap | $9.91 Trillion |
|---|---|
| Enterprise Value | $9.52 Trillion |
| Dividend Yield | $1.34 (3.54%) |
| Earnings per Share | $263.96 |
| Beta | 0.54 |
| Outstanding Shares | 1,645,606,000 |
Return
| Return on Equity | 23.50% |
|---|---|
| Return on Assets | 19.45% |
| Return on Invested Capital | 31.76% |
Valuation & Multiples
| P/E Ratio | 21.01 |
|---|---|
| PEG | 111.35 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.03 |
| Enterprise Value to Revenue | 7.06 |
| Enterprise Value to EBIT | 14.67 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 24, 2026
EPS Estimate
$0.47
Average shareholder expectationRevenue Estimate
$2.09 B
Average shareholder expectationNext Earnings Call
Expected Date
October 27, 2026
EPS Estimate
$0.48
Average shareholder expectationRevenue Estimate
$2.18 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Chugai Pharmaceutical Co., Ltd.
5,104 employees
CEO: Osamu Okuda Chugai Pharmaceutical Co., Ltd. is a prominent global pharmaceutical company, operating subsidiaries involved in the full lifecycle of drug development, from research and manufacturing to sales, import, and export, serving both Japanese ...